Maciej Mrugala

Maciej Mrugala

UNVERIFIED PROFILE

Are you Maciej Mrugala?   Register this Author

Register author
Maciej Mrugala

Maciej Mrugala

Publications by authors named "Maciej Mrugala"

Are you Maciej Mrugala?   Register this Author

55Publications

1122Reads

34Profile Views

Addressing Misdiagnosis of Optic Nerve Sheath Meningiomas.

World Neurosurg 2020 01;133:419-420

Department of Ophthalmology, Mayo Clinic, Phoenix, Arizona, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.10.122DOI Listing
January 2020

Phase II Study of Systemic High-dose Methotrexate and Intrathecal Liposomal Cytarabine for Treatment of Leptomeningeal Carcinomatosis From Breast Cancer.

Clin Breast Cancer 2019 10 18;19(5):311-316. Epub 2019 Apr 18.

Department of Medical Oncology, University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2019.04.004DOI Listing
October 2019

Next-generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Leptomeningeal Carcinomatosis: Review of 2 Cases.

Neurologist 2019 Mar;24(2):59-61

Department of Neurology, Mayo Clinic, Scottsdale, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/NRL.0000000000000220DOI Listing
March 2019

The Use of Recombinant Poliovirus for the Treatment of Recurrent Glioblastoma Multiforme.

World Neurosurg 2019 Jan 22. Epub 2019 Jan 22.

Department of Neurological Surgery, Mayo Clinic, Phoenix, Arizona; Precision Neuro-therapeutics Innovation Lab, Mayo Clinic, Phoenix, AZ; Neurosurgery Stimulation and Innovation Lab, Mayo Clinic, Phoenix, AZ; Department of Otolaryngology, Mayo Clinic, Phoenix, AZ; Department of Radiology, Mayo Clinic, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.wneu.2019.01.050DOI Listing
January 2019

Neuro-oncologists have spoken - the role of bevacizumab in the inpatient setting. A clinical and economic conundrum.

Neurooncol Pract 2019 Jan 19;6(1):30-36. Epub 2018 Apr 19.

Department of Neurology, Mayo Clinic, Phoenix, AZ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npy011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6656300PMC
January 2019

Pivotal therapeutic trials for infiltrating gliomas and how they affect clinical practice.

Neurooncol Pract 2017 Dec 26;4(4):209-219. Epub 2016 Aug 26.

University of Chicago, Department of Neurology (R.V.L.); University of Washington, Department of Neurology (M.M.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npw016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655416PMC
December 2017

Tumor Treating Fields in Neuro-Oncological Practice.

Curr Oncol Rep 2017 Aug;19(8):53

Department of Neurology and Section of Hematology and Oncology, University of Chicago, Chicago, IL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0611-8DOI Listing
August 2017

Management of Leptomeningeal Disease From Solid Tumors.

Oncology (Williston Park) 2016 08;30(8):724-30

View Article

Download full-text PDF

Source
August 2016

Primary central nervous system lymphoma treated with high-dose methotrexate and rituximab: A single-institution experience.

Oncol Lett 2016 May 30;11(5):3471-3476. Epub 2016 Mar 30.

Department of Neurology, University of Washington Medical Centre, Seattle, WA 98195, USA; Department of Neurological Surgery, University of Washington Medical Centre, Seattle, WA 98195, USA; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4393DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840907PMC
May 2016

Patient-specific metrics of invasiveness reveal significant prognostic benefit of resection in a predictable subset of gliomas.

PLoS One 2014 28;9(10):e99057. Epub 2014 Oct 28.

Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America; Nancy and Buster Alvord Brain Tumor Center, University of Washington, Seattle, Washington, United States of America; Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0099057PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211670PMC
January 2016

Improvement in Visual Fields After Treatment of Intracranial Meningioma With Bevacizumab.

J Neuroophthalmol 2015 Dec;35(4):382-6

Departments of Neurology (KIL, MMM), Neurosurgery (RCR), and Radiation Oncology (JKR), University of Washington, Seattle, Washington; and Neuro-Ophthalmic Consultants Northwest (SRH), Swedish Medical Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WNO.0000000000000253DOI Listing
December 2015

Addendum to 'A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET'.

J R Soc Interface 2015 Nov;12(112)

Department of Neurological Surgery, Northwestern University and Feinberg School of Medicine, 676 N Saint Clair Street, Suite 1300, Chicago, IL 60611, USA Northwestern Brain Tumor Institute, Northwestern University, 675 N Saint Clair Street, Suite 2100, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1098/rsif.2015.0927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4685857PMC
November 2015

Central Nervous System Cancers, Version 1.2015.

J Natl Compr Canc Netw 2015 Oct;13(10):1191-202

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Yale Cancer Center/Smilow Cancer Hospital; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; University of Michigan Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; American Brain Tumor Association; Vanderbilt-Ingram Cancer Center; Mayo Clinic Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Cancer Institute; Fred & Pamela Buffet Cancer Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Fox Chase Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.jnccn.org/content/13/10/1191.full.pdf
Web Search
http://dx.doi.org/10.6004/jnccn.2015.0148DOI Listing
October 2015

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Neuro Oncol 2015 Jun 13;17(6):854-61. Epub 2015 Jan 13.

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (J.S.); The Neurological Institute of Columbia University, New York, New York (R.K.L.); Stanford Cancer Center, Stanford, California (L.D.R.); Duke University Medical Center, Durham, North Carolina (D.A.R., G.E.A., D.D.B., J.H.S.); Evanston Northwestern Healthcare, Evanston, Illinois (N.A.P.); University of Texas M.D. Anderson Cancer Center, Houston, Texas (M.D.G.); University of Washington School of Medicine, Seattle, Washington (M.M.M.); Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah (R.J.); Yale University School of Medicine, New Haven, Connecticut (J.M.B); University Hospital-Case Medical Center & Case Comprehensive Cancer Center, Cleveland, Ohio (A.S.); Scott Cruickshank & Associates, Inc., Santa Barbara, C alifornia (S.C.); Celldex Therapeutics, Inc., Hampton, New Jersey (J.A.G., T.K., T.A.D.); University of Texas M.D. Anderson Cancer Center, Houston, Texas (A.B.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483122PMC
June 2015

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.

J R Soc Interface 2015 Feb;12(103)

Department of Neurological Surgery, Northwestern University and Feinberg School of Medicine, 676 N Saint Clair Street, Suite 1300, Chicago, IL 60611, USA Northwestern Brain Tumor Institute, Northwestern University, 675 N Saint Clair Street, Suite 2100, Chicago, IL 60611, USA.

View Article

Download full-text PDF

Source
http://rsif.royalsocietypublishing.org/content/12/103/201411
Web Search
http://rsif.royalsocietypublishing.org/cgi/doi/10.1098/rsif.
Publisher Site
http://dx.doi.org/10.1098/rsif.2014.1174DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4305419PMC
February 2015

Central nervous system cancers, version 2.2014. Featured updates to the NCCN Guidelines.

J Natl Compr Canc Netw 2014 Nov;12(11):1517-23

From University of Alabama at Birmingham Comprehensive Cancer Center; City of Hope Comprehensive Cancer Center; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; The University of Texas MD Anderson Cancer Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Washington/Seattle Cancer Care Alliance; Memorial Sloan Kettering Cancer Center; Roswell Park Cancer Institute; Duke Cancer Institute; UC San Diego Moores Cancer Center; American Brain Tumor Association; University of Michigan Comprehensive Cancer Center; St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; Massachusetts General Hospital Cancer Center; Vanderbilt-Ingram Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; Stanford Comprehensive Cancer Center; Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; Huntsman Cancer Institute at the University of Utah; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; Moffitt Cancer Center; Dana-Farber/Brigham and Women's Cancer Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4337873PMC
http://dx.doi.org/10.6004/jnccn.2014.0151DOI Listing
November 2014

Toward patient-specific, biologically optimized radiation therapy plans for the treatment of glioblastoma.

PLoS One 2013 12;8(11):e79115. Epub 2013 Nov 12.

Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0079115PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827144PMC
September 2014

Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status.

Neuro Oncol 2014 Jun;16(6):779-86

Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois (A.L.B., C.B., R.C.R., K.R.S.); Northwestern Brain Tumor Institute, Robert H. Lurie Comprehensive Cancer Center, Chicago, Ilinois (A.L.B., C.B., R.C.R., K.R.S.); Department of Pathology/Neuropathology, University of Washington School of Medicine, Seattle, Washington (K.Y., S.A., M.N., S.K.J.); Department of Pathology/Neuropathology, Stanford University, Stanford, California (D.E.B.); Department of Radiation Oncology, University of Washington School of Medicine, Seattle Washington (A.D.T., J.K.R.); Department of Integrated Mathematical Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida (D.B., J.S.); Department of Neurological Surgery, Columbia University, New York, New York (H.M., A.M.S.); Department of Pathology and Cell Biology, Columbia University, New York, New York (P.C.); Department of Neurology, University of Washington School of Medicine, Seattle, Washington (M.M.M.); Department of Applied Mathematics, University of Washington, Seattle, Washington (R.C.R., K.R.S.); Department of Engineering Sciences and Applied Mathematics, Northwestern University, Evanston, Illinois (K.R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4022227PMC
June 2014

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

J Neurooncol 2014 Mar 22;117(1):93-101. Epub 2014 Jan 22.

Department of Neurology, Northwestern University, 710 North Lake Shore Drive-Abbott Hall Room 1123, Chicago, IL, 60611, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-014-1358-9DOI Listing
March 2014

Advances and challenges in the treatment of glioblastoma: a clinician's perspective.

Authors:
Maciej M Mrugala

Discov Med 2013 Apr;15(83):221-30

University of Washington and Fred Hutchinson Cancer Research Center, 1959 NE Pacific St., Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
April 2013

Carboplatin and bevacizumab for recurrent malignant glioma.

Oncol Lett 2012 Nov 1;4(5):1082-1086. Epub 2012 Aug 1.

Departments of Neurology ; Neurosurgery and ; Fred Hutchinson Cancer Research Center, University of Washington Medical School, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2012.839DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499591PMC
November 2012

Chemoprotection in glioblastoma therapy: reality or a dream?

CNS Oncol 2012 Sep;1(1):11-4

Department of Neurology, University of Washington Medical School, 1959 NE Pacific Street, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns.12.11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176791PMC
September 2012

Outside the box--novel therapeutic strategies for glioblastoma.

Cancer J 2012 Jan-Feb;18(1):51-8

Department of Neurology, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318243f785DOI Listing
May 2012

Genetic determinants of hearing loss associated with vestibular schwannomas.

Otol Neurotol 2009 Aug;30(5):661-7

Department of Otolaryngology and Eaton Peabody Laboratory, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAO.0b013e3181a66eceDOI Listing
August 2009

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Authors:
Maciej M Mrugala

Neurology 2009 Feb;72(8):773; author reply 773-4

View Article

Download full-text PDF

Source
February 2009

Insights into the biology of primary central nervous system lymphoma.

Curr Oncol Rep 2009 Jan;11(1):73-80

Stephen E and Catherine Pappas Center for Neuro-Oncology, Yawkey 9E, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110181PMC
http://dx.doi.org/10.1007/s11912-009-0012-8DOI Listing
January 2009

Mechanisms of disease: temozolomide and glioblastoma--look to the future.

Nat Clin Pract Oncol 2008 Aug 10;5(8):476-86. Epub 2008 Jun 10.

Department of Neurology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, Washington 98106, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1155DOI Listing
August 2008

Intracranial meningiomas: an overview of diagnosis and treatment.

Neurosurg Focus 2007 ;23(4):E1

Department of Radiation Oncology, University of Washington Medical Center, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/FOC-07/10/E1DOI Listing
December 2007

Peripheral and cranial nerve sheath tumors.

Curr Opin Neurol 2005 Oct;18(5):604-10

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.wco.0000179507.51647.02DOI Listing
October 2005

Therapy for recurrent malignant glioma in adults.

Expert Rev Anticancer Ther 2004 Oct;4(5):759-82

Harvard Medical School, Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.4.5.759DOI Listing
October 2004

Neurologic complications of hematologic neoplasms.

Neurol Clin 2003 Feb;21(1):87-105

Department of Neurology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0733-8619(02)00030-0DOI Listing
February 2003

Transplanted clonal neural stem-like cells respond to remote photic stimulation following incorporation within the suprachiasmatic nucleus.

Exp Neurol 2002 Apr;174(2):162-8

Department of Neurology, University of Massachusetts Medical School, Worcester, Massachusetts 01655, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1006/exnr.2001.7857DOI Listing
April 2002